NEW
YORK, Dec. 21, 2022 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of Twist
Bioscience Corporation.
Shareholders who purchased shares of TWST during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/twist-bioscience-corporation-loss-submission-form/?id=34811&from=4
CLASS PERIOD: This lawsuit is on behalf of a class of all
persons and entities who purchased or otherwise acquired Twist
common stock between December 13,
2019 and November 14, 2022,
inclusive.
ALLEGATIONS: The complaint alleges that during the class
period, Defendants issued materially false and/or misleading
statements and/or failed to disclose that: 1) as alleged in the
November 15, 2022 report by Scorpion
Capital, defendants overstated the commercial viability of Twist's
synthetic DNA manufacturing technology; and 2) at the same time,
defendants were engaging in accounting fraud and using
unsustainable pricing to inflate the Company's true financial
condition and prospects.
DEADLINE: February 10, 2023
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/twist-bioscience-corporation-loss-submission-form/?id=34811&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of TWST during the timeframe
listed above, you will be enrolled in a portfolio monitoring
software to provide you with status updates throughout the
lifecycle of the case. The deadline to seek to be a lead plaintiff
is February 10, 2023. There is no
cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law Firm is
committed to ensuring that companies adhere to responsible business
practices and engage in good corporate citizenship. The firm seeks
recovery on behalf of investors who incurred losses when false
and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original
content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-twist-bioscience-corporation-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-february-10-2023--nasdaq-twst-301707778.html
SOURCE The Gross Law Firm